Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Hazard Rate01:11

Hazard Rate

511
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
511
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

489
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
489
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

974
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
974
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

743
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
743
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

711
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
711

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiomyopathy-Associated Mutations in a Hotspot Region at the C-Terminal Part of Desmin Coil-2 Domain Impair the Intermediate Filament Assembly.

Circulation. Genomic and precision medicine·2026
Same author

Glucagon-Like Peptide-1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Diabetes, obesity & metabolism·2026
Same author

Routine Susceptibility Testing of <i>Helicobacter pylori</i> in Clinical Practice-Results of a Prospective Multicentre Study.

Antibiotics (Basel, Switzerland)·2026
Same author

Communicating Time-to-Event Treatment Effects in Randomized Trials: A Randomized Experiment among General Practitioners.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same author

Self-rated health and mental health before and during the early phase of the COVID-19 pandemic in Germany: the population-based German National Cohort (NAKO) study.

BMC public health·2026
Same author

Reassessment of the Diagnostic Accuracy of HbA<sub>1c</sub> and Glucose for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Observational Studies.

Diabetes/metabolism research and reviews·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 7, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

A New Parametric Accelerated Failure Time Model for Semi-Competing Risks Data.

Antoniya Dineva1, Oliver Kuss2, Annika Hoyer1

  • 1Biostatistics and Medical Biometry, Medical School OWL, Bielefeld University, Bielefeld, Germany.

Statistics in Medicine
|April 6, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical method using accelerated failure time models to analyze illness-death data, accounting for semi-competing risks. The approach offers intuitive interpretations for disease onset and death, improving cohort study analysis.

Keywords:
cohort studiescompeting riskstime‐to‐event modeltruncated data

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

775

Related Experiment Videos

Last Updated: Apr 7, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

775

Area of Science:

  • Biostatistics
  • Epidemiology
  • Survival Analysis

Background:

  • Cohort studies often focus on disease occurrence, requiring accurate modeling of competing risks like death.
  • Semi-competing risks, where a terminal event (death) can censor a non-terminal event (disease), necessitate specialized statistical approaches.
  • Illness-death models, tracking transitions between healthy, diseased, and dead states, provide a framework for analyzing such data.

Purpose of the Study:

  • To introduce a novel statistical method using accelerated failure time (AFT) models for analyzing illness-death transitions.
  • To provide an intuitive interpretation of results based on survival functions, facilitating communication.
  • To develop a flexible parametric model accommodating semi-competing risks, left truncation, and interval censoring.

Main Methods:

  • Employed accelerated failure time (AFT) models for each transition in an illness-death model (healthy-diseased, healthy-dead, diseased-dead).
  • Proposed a trivariate parametric model using Weibull distributions for ages at events, incorporating random effects for intra-individual correlations.
  • Addressed methodological challenges including left truncation and interval censoring for disease onset using maximum likelihood estimation.

Main Results:

  • The proposed AFT-based illness-death model yields plausible results, consistent with existing methods in analyzing dementia onset and mortality.
  • Simulation studies demonstrate promising accuracy and numerical robustness of the new modeling approach.
  • The method effectively handles semi-competing risks, left truncation, and interval censoring inherent in cohort data.

Conclusions:

  • The AFT-based illness-death model offers a valuable and interpretable alternative for analyzing complex survival data with semi-competing risks.
  • This approach enhances the understanding of disease progression and mortality dynamics in cohort studies.
  • The model's flexibility and performance suggest broad applicability in epidemiological and clinical research.